🔎 Trials Near Me

Home › Geographic Atrophy › Maryland › Hagerstown

Geographic Atrophy clinical trials in Hagerstown, MD

5 studies for Geographic Atrophy are looking for participants at sites in and around Hagerstown (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

RecruitingPhase 2/3
  • Cumberland Valley Retina Consultants, Hagerstown
Ages 60 and older · All sexes · Updated Sep 30, 2026 · NCT06635148

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

RecruitingPhase 1/2
  • Cumberland Valley Retina Consultants - Hagerstown- Site Number : 8400003, Hagerstown
Ages 60 and older · All sexes · Updated Sep 22, 2026 · NCT07215234

A Study in Adults With Geographic Atrophy

RecruitingPhase 2
  • Cumberland Valley Retina Consultants,P.C., Hagerstown
  • Mid Atlantic Retina Specialists, Hagerstown
Ages 60 and older · All sexes · Updated Sep 21, 2026 · NCT07606365

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

RecruitingPhase 3
  • Cumberland Valley Retina Consultants-Ophthalmology, Hagerstown
  • Mid Atlantic Retina Specialist, Hagerstown
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

RecruitingPhase 2
  • Cumberland Valley Retina Consultants, Hagerstown
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445

Geographic Atrophy trials in other cities

Other studies in Hagerstown

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.